ACTRN12624000817549招募中Unknown
A randomised clinical trial of a novel pharmacist-led glucocorticoid tapering intervention for patients with rheumatic diseases
Central Adelaide Local Health Network0 个研究点目标入组 100 人开始时间: 2024年7月3日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •1.Age >=18 years
- •2.Clinical diagnosis of RA, SLE, Myositis, PMR or GCA made by a rheumatologist
- •3.New or longstanding GC use requiring tapering to lower dose or cessation over the next 6 months
排除标准
- •1.Unable to provide informed consent
- •2.Non-rheumatological indication for GC use
研究者
相似试验
已完成
不适用
Pharmacist-led home based clinical medication review in strokeTopic: Stroke Research NetworkSubtopic: Primary CareDisease: Community studyCirculatory SystemStrokeISRCTN57684399HS Lothian (UK)60
已完成
不适用
A randomised trial of a community pharmacist-initiated screening and intervention program for osteoporosis: the OsteoPharm StudyOsteoporosisISRCTN54746861niversity of Alberta (Canada)250
已完成
不适用
PCT of Pharmacopuncture Therapy for Cervical Disc Herniation: A Pilot StudyKCT0007057Jaseng Hospital of Korean Medicine84
招募中
不适用
Pragmatic randomized controlled trial of pharmacopuncture therapy for chronic low back paiKCT0006088Jaseng Medical Foundation100
进行中（未招募）
不适用
study of effective pharmacological cardioversion of paroxysmal atrial fibrillation with flecainide vs vernakalantAtrial fibrillation paroxysmalMedDRA version: 17.1Level: LLTClassification code 10003661Term: Atrial fibrillation paroxysmalSystem Organ Class: 100000004849EUCTR2014-003641-95-ESicasio Pérez Castellano